key: cord-0985784-nvhkj9tk
authors: Cantero, Chloé; Pasquina, Patrick; Dao, Melissa Dominicé; Cedraschi, Christine; Adler, Dan; Plojoux, Jérôme; Janssens, Jean-Paul
title: Impact of Confinement in Patients under Long-Term Noninvasive Ventilation during the First Wave of the SARS-CoV-2 Pandemic: A Remarkable Resilience
date: 2021-06-15
journal: Respiration
DOI: 10.1159/000516327
sha: c368615c12a0fbb563f1da8515ff39fba8fefe18
doc_id: 985784
cord_uid: nvhkj9tk

BACKGROUND: During the first wave of the SARS-CoV-2 pandemic in Switzerland, confinement was imposed to limit transmission and protect vulnerable persons. These measures may have had a negative impact on perceived quality of care and symptoms in patients with chronic disorders. OBJECTIVES: To determine whether patients under long-term home noninvasive ventilation (LTHNIV) for chronic respiratory failure (CRF) were negatively affected by the 56-day confinement (March–April 2020). METHODS: A questionnaire-based survey exploring mood disturbances (HAD), symptom scores related to NIV (S3-NIV), and perception of health-care providers during confinement was sent to all patients under LTHNIV followed up by our center. Symptom scores and data obtained by ventilator software were compared between confinement and the 56 days prior to confinement. RESULTS: Of a total of 100 eligible patients, 66 were included (median age: 66 years [IQR: 53–74]): 35 (53%) with restrictive lung disorders, 20 (30%) with OHS or SRBD, and 11 (17%) with COPD or overlap syndrome. Prevalence of anxiety (n = 7; 11%) and depressive (n = 2; 3%) disorders was remarkably low. Symptom scores were slightly higher during confinement although this difference was not clinically relevant. Technical data regarding ventilation, including compliance, did not change. Patients complained of isolation and lack of social contact. They felt supported by their relatives and caregivers but complained of the lack of regular contact and information by health-care professionals. CONCLUSIONS: Patients under LTHNIV for CRF showed a remarkable resilience during the SARS-CoV-2 confinement period. Comments provided may be helpful for managing similar future health-care crises.

On February 25, 2020, the first case of SARS-CoV-2 infection was identified in Switzerland, 3 months after the beginning of the major pandemic, which has so far in-

In the Geneva area, patients under long-term HMV are cared for both by pulmonologists in private practice and by local hospitals, with the support of health care providers [19] . The present study focuses on patients under HMV who were followed up by the Division of Pulmonary Diseases of Geneva University Hospitals at the time of confinement. These patients usually have elective follow-up visits at our hospital (every 3-6 months) and home visits by specialized nurses either electively or on demand. Most patients are also telemonitored, and hotlines (weekdays and work hours) are available for HMV-related problems (technical support and specialized nurse).

At the beginning of the confinement, scheduled elective inhospital visits and home visits were canceled; however, hotlines were maintained. When appropriate (average daily use >16 h/day), a second home ventilator was made available. Furthermore, all ventilator-dependent patients received spare tubings and interfaces to minimize the risk of technical problems.

Just after the confinement period, we designed a questionnairebased study to analyze the impact of confinement on this population. We explored 3 domains: 1. Symptoms and side effects related to NIV, using the S 3 -NIV score, designed by our group [20] and used routinely during hospital visits in our center. This 11-item scale includes 2 subscores: "respiratory symptoms" and "sleep and NIV-related side effects" such as discomfort caused by leaks, interface, or xerostomia. The score ranges from 0 to 10, and higher values indicate less symptoms or side effects related to NIV. When available, S 3 -NIV scores obtained prior to the confinement (within 6 months) were compared to values related to the confinement period. 2. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS) [21, 22] . This 14-item questionnaire includes 2 subgroups: 7 focused on anxiety and 7 on depression. The score ranges from 0 to 42, and a value <8 is considered normal, between 8 and 10 is considered borderline, and >10 is suggestive of an anxiety and/or a depression disorder. Although not specifically designed for patients under HMV, this score has been widely used for documenting the prevalence of anxiety and depression disorders in patients with chronic respiratory disorders including patients with HMV and recently used as an anchor for quantifying the minimal clinically important difference of the Severe Respiratory Questionnaire [23] [24] [25] [26] [27] [28] , compliance, and daily use) were retrieved either through our telemonitoring platform or during home visits and compared to the 56 days preceding the confinement period. Questionnaires were sent by post to the patients' homes with a reminder after 1 month and then after 6 weeks. The study protocol was accepted by our local ethics committee (2020-01509) and registered at clinicaltrials.gov (NCT04477473).

All data were described as frequency and percentage for qualitative data and as mean and standard deviation or median and interquartile range (IQR) for quantitative data. HADS scores measured just after the confinement were compared between diagnostic groups ([1] COPD and overlap syndrome; [2] restrictive lung disorders including neuromuscular disorders [NMD], and [3] obesity hypoventilation syndrome [OHS] and sleep-related breathing disorders [SRBD]) using a linear regression model. Data concerning S 3 -NIV were compared between both periods (before and during the confinement) using paired t tests. Data provided by ventilator software were compared between periods using Wilcoxon signed rank tests with continuity corrections. Missing data were not replaced but simply reported to reflect the real-life nature of the study. Statistical significance was set at a 2-sided level of 5% for all analyses. All analyses were performed using R software version R-4.0.2 (R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org).

The flowchart (Fig. 1) shows the recruitment process. The day before confinement, 117 patients under HMV were followed up by the Division of Pulmonary Diseases of Geneva University Hospitals. Four patients died during the confinement period, 3 of COVID-19 infection and 1 of non-COVID-19 infection, and thus could not be included. After exclusion of 13 other patients because of language or cognitive barriers, 100 patients were eligible and solicited for the present study. Thirty-four patients refused to participate or did not reply and 66 accepted and provided answers to the 3 questionnaires. Sixty-two patients of the 100 included were telemonitored (Air-View ® ; ResMed). All patients included were on NIV.

There was no significant difference between the 34 patients who refused inclusion and the study population Distribution of diagnoses differed however with a participation rate of roughly 80% in patients with "COPDoverlap syndrome" and "restrictive lung disorders" (including NMD) versus only 50% in the "OHS and SRBD" group (p = 0.012).

Baseline characteristics of the study population are described in Table 1 . NMD were the largest group in this study (details of diagnoses are given in online suppl. Table 1S; see www.karger.com/doi/10.1159/000516327 for all online suppl. material). S 3 -NIV Score S 3 -NIV scores were available in 42 patients before and during confinement ( Table 2) . Total score was slightly higher before confinement than during confinement (mean difference = 0.36 [95% CI: 0.04-0.69], p = 0.029) while subscores did not differ significantly between periods. Missing values prior to confinement were mostly related to severely limited patients who had NMD or severe COPD: in these patients, elective follow-up visits were performed mostly at home, and S 3 -NIV was not collected.

For all patients, S 3 -NIV scores provided just after the confinement (n = 66) were 7.1 (IQR: 5.4; 7.9) for "respira- tory symptoms" and 7.5 (IQR: 6; 9) for "sleep and side effects." The median total score was 7.5 (IQR: 5.9; 8).

Three patients did not answer all of the 14 questions. Among the remaining patients, 7 (11%) had scores suggestive of an anxiety disorder (HAD-A >10) and 2 (3%) of depression (HAD-D >10). Anxiety and depression scores did not differ significantly between diagnostic groups (online suppl. Fig. 1S ). HAD scores were provided only for the confinement period.

Technical Data Related to NIV Fifty-eight patients (88%) used ResMed devices (S9 VPAP ST ® , Lumis 150 ® , Stellar 150 ® , or Astral 150 ® ), 5 (8%) used Philips Respironics devices (BiPAP A40 ® ), and 1 patient (1%) an Air Liquide device (Monnal T50 ® ). Data were missing for 2 patients.

During the confinement, most patients (50/64, 78%) used their ventilator every day, and only 4 patients (6%) used their ventilator <28 days (i.e., 50% of the confinement period). This was similar to what was observed during the 56 days before confinement: 46/63 patients (73%) used their ventilator every day and only 2 patients (3%) used their ventilator <28 days.

When patients used their ventilator, they used it on average 8.4 (SD 3.5) hours per day before and 8.6 (3.8) hours per day during the confinement (mean difference = 15 min, 95% CI: 0-30, p = 0.050). Because data summaries (leaks, respiratory rate, and percentage of triggered breaths) provided by ventilator software differ between manufacturers, comparisons were made only for data from ResMed devices (n = 58; Table 3 ). No significant difference was found for unintentional leaks, percentage of triggered breaths, backup respiratory rate, and apnea-hypopnea index (AHI) between both study periods (Table 3) .

None of the study patients was treated at home or hospitalized for a COVID-19 infection during the confinement, and 3 patients were hospitalized for a non-CO-VID-19 pulmonary infection. Four patients were treated at home for a lower respiratory tract infection according to a predefined action plan. None of the patients required an emergency home medical visit. No technical problem occurred with NIV devices and/or oxygen extractors. Few patients (n = 3; 5%) expressed concern about the possibility of a lack of technical support in case of problems with their NIV and/or oxygen extractor. During the confinement, elective evaluations of NIV were canceled in 24 cases (36%), home visits by nurses in 19 cases (29%), and home chest therapy or rehabilitation in 17 patients (26%).

Approximately half of the patients surveyed (n = 36) provided free-text comments to at least one of the 3 open questions regarding their difficulties, expectations, and resources during the COVID-19 period ( Table 4 ). The main difficulties expressed by our patients during the confinement period were having to stay homebound and lack of physical activities (n = 9, 28% of responses), lack of social contact with friends and family (n = 5, 16%), and cancellation of their health-care appointments (n = 3, 9%). Patients related that outside help, contact with their loved ones (n = 11, 33%), keeping a normal daily rhythm and regular physical activity (n = 5, 15%), and finding a source of distraction (n = 4, 12%) were all helpful to them to maintain good physical and mental health. Patients spontaneously made grateful and positive comments on the care and information provided by their health professionals during confinement (n = 14, 58%) although a few wished for more phone contact and information regarding contagion (n = 6, 25%). A selection of relevant freetext comments is provided in Table 4 . 

This study explored the perception of confinement related to the COVID-19 pandemic and its impact on health care in patients under long-term home NIV. The response rate to our mailing was high (two-thirds of patients solicited) for this type of study. Among respondents to the questionnaire, we noticed that the prevalence of anxiety (11%) and depression (3%) was remarkably low. When compared to baseline values, the confinement period was associated with minor increases in symptoms of CRF or reported side effects of NIV. Respiratory rate, unintentional leaks, apnea-hypopnea index, and compliance to NIV, all markers of appropriate use of the ventilator and efficacy downloaded from the ventilator, were unchanged. Daily use of the ventilator increased on average by 15 min during the confinement, which was not considered as clinically relevant. Targeted questions revealed that home treatments (nurse visits, chest therapy, and rehabilitation) were interrupted in a quarter of respondents, and elective evaluations were canceled or postponed in close to 40%. Technical problems were rare. Patients mentioned the weight of social isolation and the importance of their close relatives as a psychological support.

We had anticipated a higher prevalence of anxiety and depression and a more important impact of social isolation on compliance to NIV and symptom scores. This was not the case. Indeed, the impact of isolation and decreases in social interactions and relationships on morbidity and mortality has been documented in subjects with preexisting health conditions [29] [30] [31] . Although patients did mention social isolation as a problem, HAD scores were well within or below published values for patients under HMV, with a remarkably low prevalence of anxiety or depressive disorders in spite of the pandemic [27, [32] [33] [34] [35] [36] [37] . Interestingly, a Spanish study which included 100 patients with COPD reported that patients' feelings regarding their lung disease and general health were similar or even better during lockdown [38] . There are a few plausible contributive factors. Patients on HMV are most often sedentary and very few have a regular (often part-time) professional activity (17% in our study population). Also, although 90% of patients can leave their home, it is for many neuromuscular patients (48% of the study population), a complicated and sometimes tedious exercise. Furthermore, even if some therapeutic interventions were discontinued during the confinement, many neuromuscu- Data were available for both periods in 42 patients; the score ranges from 0 to 10, and higher values indicate less symptoms or side effects related to NIV. CI, confidence interval; n, number of patients; NIV, noninvasive ventilation. * Paired t test. Values are expressed as median (IQR) or frequency (%); data were available for both periods in 58 patients using ResMed devices. AHI, apnea-hypopnea index; n, number of patients. * Wilcoxon signed rank test with continuity correction.

Cantero/Pasquina/Dao/Cedraschi/Adler/ Plojoux/Janssens Respiration 6 DOI: 10.1159/000516327 lar patients rely on a group of caregivers which in most cases did not change. Therefore, the real impact on the environment of neuromuscular patients may have been limited.

Symptom scores were also within expected values for this population [20] . There was a minor statistically significant decrease in the total S 3 -NIV score during the confinement. Subscores of the S 3 -NIV did not show, how- Being homebound (n = 9) Always being at home and not able to do my usual activities

Not being able to go out, I was locked up 24 h a day Feeling isolated (from the outside world, family, and friends, n = 5)

The lack of contact with the outside world The open questions provided important additional insights. Patients found difficult the confinement per se, the isolation, and the resulting lack of contact with the outside world. Lack of exercise, physiotherapy, and rehabilitation was also problematic. Although there were many positive comments regarding health-care professionals, several patients would have liked more information and contact: they expressed their desire for regular phone calls by HCW, for being updated on the COVID-19 situation and how it impacted on their situation, for reassurance as to the persisting availability of technical support and equipment. Our focus at the beginning of the first wave of the pandemic was mostly on logistics: providing enough backup equipment (extra interfaces, tubings, filters, and low threshold for a backup ventilator) and information (hotlines) in case of technical problems. This suggests that some form of teleconsultation should be added to the well-accepted telemonitoring, implemented routinely in most patients. The support provided by close relatives, family members, and caregivers and HCW was also of major importance.

There are a few limitations to this pragmatic observational study: first, the distribution of diagnoses in the study population differed from larger studies of NIV in our area [19] : almost half of them had NMD, and all patients had been on HMV for a prolonged period. The lower participation rate of patients with OHS and SRBD may have affected results concerning SARS-CoV-2 morbidity and mortality since OHS patients are a high-risk group for COVID-19 infection. This case selection is related to our focus, as a University Hospital, on more complex cases, with a higher burden placed on caregivers. This may have had an impact on our results.

Second, we could not compare S 3 -NIV scores before and during confinement for 24 patients: S 3 -NIV is not always collected during home visits (more frequent in NMD patients). S 3 -NIV scores obtained for all patients during the confinement are quite close to those collected prior to confinement, suggesting that significant changes were unlikely.

Third, these results are related to specific standards of care in our area and to geographic and socioeconomic characteristics of Geneva. Extrapolating these results to other environments and ethnic/socioeconomic groups may not be possible. This is also the case for patients ventilated by tracheostomy, none of whom were included in this study: home invasive ventilation is a very rare occurrence in our area [19] .

Fourth, we chose to use the HADS as a questionnaire designed for screening for anxiety and depression in chronic disorders. Although not specifically designed for HMV patients, it is widely used in these patients by expert groups, simple to perform, and short [24-27, 32, 35, 36] . We did not add a questionnaire such as the Severe Respiratory Insufficiency (SRI) questionnaire [39] , designed for assessing health-related quality of life in patients under HMV. This was a strategic choice: we feared that adding 49 questions to the 65 items already submitted to our patients might compromise the response rate and/or the quality of the responses. Also, HRQL per se was not the main focus of this study, even if several items contributing to HRQL were assessed through the use of the HADS and the S 3 -NIV. The SRI could have contributed additional information on HRQL, through a more detailed assessment for instance of activities of daily life, psychosocial aspects, and symptoms. Finally, this study focused on the first wave of the pandemic in our area: the second wave which has hit most countries worldwide may prove to be more difficult to accept because of the fatigue, the lassitude by this persistent situation, and the impact on families, caregivers, and health-care workers.

The combination of a low prevalence of anxiety and depression, favorable symptom scores, and excellent and stable compliance suggests a remarkable resilience during the first wave of the SARS-CoV-2 pandemic in this vulnerable population of patients under HMV for CRF. Suggestions provided by the patients such as providing more regular phone contacts and information regarding SARS-CoV-2 in their particular situation may be helpful during the second wave of the pandemic.

The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness

COVID-19 crisis effects on caregiver distress in neurocognitive disorder

Living with dementia: increased level of caregiver stress in times of COVID-19

The bulle: support and prevention of psychological decompensation of health care workers during the trauma of the COVID-19 epidemic

Psychological aspects and eating habits during COVID-19 home confinement: results of EHLC

Italian online survey

Effects of CO-VID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 international online survey

Psychological consequences of COVID-19 home confinement: the ECLB-COVID19 multicenter study

Psychological symptoms of the outbreak of the COVID-19 confinement in Spain

Longitudinal evaluation of the psychological impact of the COVID-19 crisis in Spain

Impact of social isolation due to COVID-19 on health in older people: mental and physical effects and recommendations

Changes in dietary behaviours during the COVID-19 outbreak confinement in the Spanish COVIDiet study

Resilience and physical activity in people under home isolation due to COVID-19: a preliminary evaluation

COVID-19, psychological well-being and physical activity levels in older adults during the nationwide lockdown in Spain

Epilepsy in time of COVID-19: a survey-based study

Influence of the COVID-19 outbreak in people with epilepsy: analysis of a Spanish population (EPICOVID registry)

Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase

Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease

Impact of home confinement during the COVID-19 pandemic on medication use and disease activity in spondyloarthritis patients

Long term noninvasive ventilation in the Geneva Lake area: indications, prevalence and modalities

Development and validation of a simple tool for the assessment of home noninvasive ventilation: the S(3)-NIV questionnaire

Evaluation of anxiety and depression among patients hospitalized on an internal medicine service

The hospital anxiety and depression scale

The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire in severe COPD

Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial

Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD

Health-related quality of life in COPD patients with chronic respiratory failure

Quality of life in long term ventilated adult patients with Duchenne muscular dystrophy

Quality of life of patients under home mechanical ventilation for restrictive lung diseases: a comparative evaluation with COPD patients. Monaldi Arch Chest Dis

SARS-CoV-2 Pandemic Confinement in Patients on Home Mechanical Ventilation 9

Why social relationships are important for physical health: a systems approach to understanding and modifying risk and protection

Loneliness and social isolation as risk factors for CVD: implications for evidence-based patient care and scientific inquiry

Social relationships and mortality risk: a meta-analytic review

Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial

Does the "oxygen cost diagram" reflect changes in six minute walking distance in follow up studies?

The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: air hunger, anxiety and fear

Comparison of different disease-specific health-related quality of life measurements in patients with long-term noninvasive ventilation

Which are the factors influencing NIV adaptation and tolerance in ALS patients?

The Severe Respiratory Insufficiency Questionnaire scored best in the assessment of health-related quality of life in chronic obstructive pulmonary disease

The experience of COPD patients in lockdown due to the COVID-19 pandemic

The Severe Respiratory Insufficiency (SRI) Questionnaire: a specific measure of health-related quality of life in patients receiving home mechanical ventilation

We are grateful to Antoine Poncet for the statistical analyses and his thorough revision of the manuscript.The authors declare that they have no conflicts of interest.

The authors declare that no funding was provided for this study.

Chloé Cantero, Patrick Pasquina, and Jean-Paul Janssens contributed to the conception and design of the study. Chloé Cantero and Patrick Pasquina organized the database. Chloé Cantero and Jean-Paul Janssens wrote the first draft of the manuscript. Chloé Cantero, Patrick Pasquina, Melissa Dominicé Dao, Christine Cedraschi, Dan Adler, Jérôme Plojoux, and Jean-Paul Janssens wrote sections of the manuscript. All authors contributed to manuscript revision and read and approved the submitted version.